Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer (Mainsail)
This study is ongoing, but not recruiting participants.
Study NCT00988208
Information provided by Celgene Corporation
First Received on October 1, 2009.
Last Updated on September 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
